PureTech News

Press Releases
ALL >
Press Release - 2024-12-16
Internal Program - LYT-100
PureTech’s Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b Trial
Continue
Press Release - 2024-12-11
Seaport
PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024
Continue
Press Release - 2024-12-09
Gallop Oncology – LYT-200
Other
PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting
Continue
Publications
ALL >
Publications 2024-03-04
Validating the efficacy and value proposition of mental fitness vocal biomarkers in a psychiatric population: prospective cohort study
Full Article
Publications 2023-04-15
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection
Full Article
Publications 2022-04-13
Cell Host & Microbe: Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers
Full Article

@PureTechH